Does TRASTUZUMAB DERUXTECAN Cause Lung opacity? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Lung opacity have been filed in association with TRASTUZUMAB DERUXTECAN (Enhertu). This represents 0.4% of all adverse event reports for TRASTUZUMAB DERUXTECAN.
11
Reports of Lung opacity with TRASTUZUMAB DERUXTECAN
0.4%
of all TRASTUZUMAB DERUXTECAN reports
1
Deaths
2
Hospitalizations
How Dangerous Is Lung opacity From TRASTUZUMAB DERUXTECAN?
Of the 11 reports, 1 (9.1%) resulted in death, 2 (18.2%) required hospitalization.
Is Lung opacity Listed in the Official Label?
Yes, Lung opacity is listed as a known adverse reaction in the official FDA drug label for TRASTUZUMAB DERUXTECAN.
What Other Side Effects Does TRASTUZUMAB DERUXTECAN Cause?
Death (384)
Off label use (258)
Nausea (251)
Myelosuppression (242)
Fatigue (186)
Malignant neoplasm progression (171)
Vomiting (140)
Diarrhoea (132)
Interstitial lung disease (130)
Pneumonitis (125)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which TRASTUZUMAB DERUXTECAN Alternatives Have Lower Lung opacity Risk?
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DKST
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DTTB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-PKRB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-QYYP